Researchers at Uppsala University have created the first 3D map of the hearing nerve showing where the various sound frequencies are captured. Using what is known as synchrotron X-ray imaging, they ...
FX-322 is Frequency’s lead product candidate, designed to regenerate auditory sensory hair cells in the cochlea and improve hearing in patients with sensorineural hearing loss (SNHL). A Phase 1/2 ...
Cochlear implants are among the most successful neural prostheses on the market. These artificial ears have allowed nearly 1 million people globally with severe to profound hearing loss to either ...
Researchers have created the first 3D map of the hearing nerve showing where the various sound frequencies are captured. Using what is known as synchrotron X-ray imaging, they were able to trace the ...
Top-Line Results Show Consistent Drug Entry in All Patients WOBURN, Mass.--(BUSINESS WIRE)-- Frequency Therapeutics, Inc. (Nasdaq: FREQ), today announced top-line data from an exploratory clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results